Insider Purchases: Inside the Buy

Tag: buy or sell BSX

Cinematic illustration of Boston Scientific as a futuristic medtech powerhouse, with glowing cardiovascular devices, a heart-shaped stock chart, doctors, investors, and a $2B buyback shield symbolizing healthcare innovation and a GARP stock opportunity.

🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse

Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.

Read entire article

Tags: Boston Scientific, BostonScientific, BSX, BSX stock, buy or sell BSX, cardiovascular devices, CardiovascularTech, dividend growth stocks, FARAPULSE, featured-insiders, FUNanc1al, GARP, GARP investing, growth stocks, healthcare investing, healthcare stocks, hub-insiders, insider buying, InsiderBuying, medical device stocks, medical technology, MedicalDevices, MedTech, medtech stocks, NYSE BSX, risks buying BSX, ShareRepurchase, stock buyback, stock market analysis, value investing, ValueInvesting, WATCHMAN FLX, why buy BSX